Becton, Dickinson and Company (BDX)
| Market Cap | 68.58B |
| Revenue (ttm) | 19.72B |
| Net Income (ttm) | 1.32B |
| Shares Out | 289.01M |
| EPS (ttm) | 4.51 |
| PE Ratio | 52.62 |
| Forward PE | 17.11 |
| Dividend | $3.80 (1.60%) |
| Ex-Dividend Date | Sep 9, 2024 |
| Volume | 1,376,600 |
| Open | 234.78 |
| Previous Close | 232.78 |
| Day's Range | 232.38 - 239.22 |
| 52-Week Range | 218.75 - 285.49 |
| Beta | 0.44 |
| Analysts | Buy |
| Price Target | 283.13 (+19.31%) |
| Earnings Date | Aug 1, 2024 |
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascula... [Read more]
Financial Performance
In 2023, BDX's revenue was $19.37 billion, an increase of 2.66% compared to the previous year's $18.87 billion. Earnings were $1.42 billion, a decrease of -15.69%.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $283.13, which is an increase of 19.31% from the latest price.
News
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J.
BD Board Declares Dividend
FRANKLIN LAKES, N.J. , July 23, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decla...
Becton Dickinson's stock bounces as FDA addresses supply issue with blood-culture vials
Medical-supply company looks to fill gaps as former supplier restarts production of vials.
US FDA flags shortage of Becton Dickinson's blood test tubes
The U.S. Food and Drug Administration issued an alert on Wednesday to laboratories and healthcare providers of a shortage of Becton Dickinson' blood test tubes used in diagnosing bacterial and fungal ...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Com...
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
FRANKLIN LAKES, N.J. , July 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1 and 2 sc...
BD to Announce Financial Results for its Third Quarter of Fiscal 2024
FRANKLIN LAKES, N.J. , July 3, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results f...
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD Rhapsody™ ATAC-Seq Assay Helps Researchers Understand DNA Regulation and Enable Advancements in Precision Medicine FRANKLIN LAKES, N.J. , June 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Com...
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
FRANKLIN LAKES, N.J. , June 20, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to disc...
Time Sensitive - Reminder from Levi & Korsinsky, LLP to File Claim for Share of Becton, Dickinson and Company (BDX) Settlement Fund Before Deadline
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE: BD...
Looming Deadline - Levi & Korsinsky Encourages Shareholders of Becton, Dickinson and Company (BDX) to File a Share in Class Action Recovery
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE: BDX...
Becton Dickinson Buys Critical Care Unit From Edwards Lifesciences for $4.2B
Shares of Becton Dickinson (BDX) advanced close to 3% Monday as the maker of syringes and other medical devices announced it was buying the Critical Care product unit of Edwards Lifesciences (EW) for ...
Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash
The buyer intends to fund deal with a combination of $1 billion in cash and $3.2 billion of new debt in a transaction that is one of its largest of many.
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
Edwards Lifesciences on Monday said it has agreed to sell its Critical Care products unit to Becton Dickinson in an all-cash transaction valued at $4.2 billion.
Edwards Lifesciences to sell its critical care product group for $4.2 billion to Becton Dickinson
Shares of Edwards Lifesciences Corp. EW, -1.14% rallied 3% in premarket trading Monday, after the company announced an agreement to sell its critical care product group to Becton Dickinson & Co. BDX, ...
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands ...
Edwards Lifesciences to Sell Critical Care to BD
IRVINE, CA--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (N...
Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX)...
Women in U.S. Can Now Collect Their Own Sample for Cervical Cancer Screening
FRANKLIN LAKES, N.J. , May 15, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA)...
Cramer's Mad Dash: Becton Dickinson and Co. and Owens & Minor
CNBC's Jim Cramer delivers his daily Mad Dash.
Becton Dickinson lifts profit view on strong surgical equipment demand
Becton Dickinson raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment and syringes.
BD Reports Second Quarter Fiscal 2024 Financial Results
Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic Q2 GAAP and adju...
BD to Present at Bank of America Securities Health Care Conference 2024
FRANKLIN LAKES, N.J. , April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of A...
BD Named a Best Employer for Excellence in Employee Well-Being
FRANKLIN LAKES, N.J. , April 9, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Grou...
BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters
New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of Discovery FRANKLIN LAKES, N.J. , April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),...